MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
171.40%
Quick Ratio
171.40%
Debt to Asset Ratio
47.73%
Unit: Thousand (K) dollars
Assets Breakdown
    • Unbilled receivable from governm...
    • Prepaid clinical services, long-...
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
50,746 53,814 16,880 20,111
Short-term investments
10,276 9,993 11,913 6,160
Accounts receivable
7,139 14,564 42,716 4,281
Unbilled receivable from government contracts
50,435 36,781 43,229 36,781
Prepaid expenses and other current assets
13,108 20,971 2,632 3,046
Total current assets
131,704 136,123 117,370 70,379
Property and equipment, gross
19,385 19,234 NaN NaN
Less accumulated depreciation
14,558 13,801 NaN NaN
Property and equipment, net
4,827 5,433 6,064 6,926
Prepaid clinical services, long-term
25,218 25,218 60,116 60,116
Right-of-use assets, net
10,642 11,432 17,097 18,137
Intangible assets, net
2,643 2,826 3,009 3,192
Goodwill
4,508 4,508 4,508 4,508
Other long-term assets
513 539 824 827
Total assets
180,055 186,079 208,988 164,085
Accounts payable
24,185 21,496 53,075 10,611
Deferred revenue-Government Contract
23 68 64,828 65,377
Deferred revenue-Collaboration Revenue
11,716 12,952 NaN NaN
Other accrued current liabilities
36,526 47,879 44,882 35,727
Current portion of operating lease liability
2,530 2,978 3,783 3,486
Current portion of liability related to sale of future royalties
1,862 1,381 2,732 2,677
Total current liabilities
76,842 86,754 169,300 117,878
Operating lease liability, net of current portion
5,438 6,007 11,661 12,627
Deferred collaboration revenue, net of current portion
445 2,024 NaN NaN
Liability related to sale of future royalties, net of current portion
2,372 2,679 782 230
Other long-term liabilities
841 817 489 472
Total liabilities
85,938 98,281 182,232 131,207
Common stock 0.0001 par value 350,000,000 shares authorized as of march 31, 2026 and december 31, 2025 242,169,130 shares issued and 241,414,053 shares outstanding as of march 31, 2026 and 240,742,681 shares issued and 240,494,594 shares outstanding as of december 31, 2025
24 24 23 23
Additional paid-in capital
549,613 548,131 542,346 540,328
Treasury stock at cost, 755,077 shares as of march 31, 2026 and 248,087 shares as of december 31, 2025
497 159 371 367
Accumulated deficit
-455,016 -460,195 -515,240 -507,099
Accumulated other comprehensive loss
-7 -3 -2 -7
Total stockholders equity
94,117 87,798 26,756 32,878
Total liabilities and stockholders equity
180,055 186,079 208,988 164,085
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$50,746K Unbilled receivable fromgovernment contracts$50,435K Prepaid expenses andother current assets$13,108K Short-term investments$10,276K Accounts receivable$7,139K Property and equipment,gross$19,385K Total current assets$131,704K Prepaid clinicalservices, long-term$25,218K Right-of-use assets, net$10,642K Property and equipment,net$4,827K Goodwill$4,508K Intangible assets, net$2,643K Other long-termassets$513K Less accumulateddepreciation$14,558K Total assets$180,055K Total liabilities andstockholders equity$180,055K Total stockholdersequity$94,117K Total liabilities$85,938K Accumulated deficit-$455,016K Treasury stock at cost,755,077 shares as of...$497K Accumulated othercomprehensive loss-$7K Additional paid-in capital$549,613K Total currentliabilities$76,842K Operating leaseliability, net of current...$5,438K Liability related to saleof future...$2,372K Other long-termliabilities$841K Deferred collaborationrevenue, net of current...$445K Common stock 0.0001 parvalue 350,000,000...$24K Other accrued currentliabilities$36,526K Accounts payable$24,185K Deferredrevenue-Collaboration Revenue$11,716K Current portion ofoperating lease liability$2,530K Current portion ofliability related to sale...$1,862K Deferredrevenue-Government Contract$23K

Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT)